Tag: Genentech
Genentech MS drug Ocrevus approved by FDA for multiple sclerosis treatment
Roche Group’s subsidiary Genentech has secured the US FDA approval for its multiple sclerosis drug, Ocrevus (ocrelizumab) for treating both relapsing and primary progressive variants ... Read More